Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Condrosulf versus Celebrex versus placebo in knee osteoarthritis
2013-001619-62Phase 3Completed
- Sponsor
- IBSA Group
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Condrosulf, Celebrex and Placebo (3 arms). Primary endpoints: Change in Lequesne algo-functional index from day 1 to day 182 and Change in pain visual analogue scale from day 1 to day 182. Started Dec 2013; status: completed.
02
Drugs
chondroitin sulfatecelecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2013-001619-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001619-62.